1. Sweden Stocks

  2. •

    Healthcare

  3. •

    Medical - Specialties
Boule Diagnostics AB

Boule Diagnostics AB

BOUL.ST
Boule Diagnostics ABSE flagStockholm Stock Exchange
3.89
SEK
- -
- -
151.06MMarket Cap

Total Valuation

Boule Diagnostics AB carries a market capitalization of 151.06M, placing it among publicly traded companies globally. Its enterprise value stands at 519.80M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap151.06M
Enterprise Value519.80M

Share Statistics

Boule Diagnostics AB currently has 38.83M shares outstanding.

Shares Outstanding38.83M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 0.65, and the price-to-book ratio stands at -1.65.

PE RatioN/A
PS Ratio0.65
PB Ratio-1.65
P/TBV Ratio4.50
P/FCF Ratio9.08
P/OCF Ratio34.19

Enterprise Valuation

EV / Sales1.01
EV / EBITDAN/A
EV / EBITN/A
EV / FCF10.27

Financial Position

Boule Diagnostics AB maintains a current ratio of 1.02, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 128.61, indicating elevated leverage, while an interest coverage ratio of -19.92 demonstrates limited ability to service its debt obligations.

Current Ratio1.02
Quick Ratio0.10
Debt / Equity128.61
Debt / EBITDA-0.63
Interest Coverage-19.92

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)-50.57
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)465.85
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover4.21

Taxes

Over the trailing twelve months, Boule Diagnostics AB has paid -65.70M in income taxes, reflecting an effective tax rate of 330.00.

Income Tax-65.70M
Effective Tax Rate330.00

Stock Price Statistics

Boule Diagnostics AB's stock has declined approximately -57.53275% over the past 52 weeks. The 50-day moving average sits at 3.43, while the 200-day moving average is 4.54.

Beta (5Y)N/A
52-Week Price Change-57.53275%
50-Day Moving Average3.43
200-Day Moving Average4.54
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Boule Diagnostics AB generated 516.00M in revenue and converted that into -320.70M in net income, yielding earnings per share of -8.35. EBITDA reached -328.60M, while operating income came in at -328.60M.

Revenue516.00M
Gross Profit228.60M
Operating Income-328.60M
Pretax Income-386.40M
Net Income-320.70M
EBITDA-328.60M
EBIT-328.60M
Earnings Per Share (EPS)-8.35

Balance Sheet

Boule Diagnostics AB holds 23.00M in cash and equivalents against 207.70M in total debt, resulting in a net debt position of 177.60M. Total book value stands at -203.20M, with working capital of 5.40M providing operational flexibility.

Cash & Cash Equivalents23.00M
Total Debt207.70M
Net Debt177.60M
Equity (Book Value)-203.20M
Book Value Per Share-5.29
Working Capital5.40M

Cash Flow

Boule Diagnostics AB produced 9.80M in operating cash flow over the past twelve months. After subtracting -27.10M in capital expenditures, free cash flow totaled -17.30M - equivalent to -0.45 per share.

Operating Cash Flow9.80M
Capital Expenditures-27.10M
Free Cash Flow-17.30M
FCF Per Share-0.45

Margins

Boule Diagnostics AB operates with a gross margin of 44.30, reflecting its pricing power and cost economics. The operating margin of -63.68 and net profit margin of -62.15 provide insight into operational efficiency.

Gross Margin44.30
Operating Margin-63.68
Pretax Margin-74.88
Profit Margin-62.15
EBITDA Margin-63.68

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-6.48
FCF Yield11.01

Stock Splits

Boule Diagnostics AB's most recent stock split took place on November 9, 2022 with a 250:353 split ratio.

Last Split Date11/9/2022
Split Ratio250:353

Scores

Boule Diagnostics AB posts an Altman Z-Score of -1.61, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-1.61